Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

HPA2b Inhibitors

HPA2b inhibitors belong to a specialized class of compounds that modulate the activity of a specific enzyme or protein, often associated with biological processes involving hydrolytic reactions. These inhibitors typically function by binding to the active or allosteric sites of HPA2b, preventing the normal enzymatic function, such as the breakdown of particular substrates. Structurally, HPA2b inhibitors can vary, with some being small organic molecules while others may be larger, more complex entities. Their binding interactions with the target protein can involve hydrophobic contacts, hydrogen bonding, or even covalent modifications, depending on the specific nature of the inhibitor. As a result, these compounds can be fine-tuned to have varying degrees of specificity and affinity toward HPA2b.

In terms of chemical properties, HPA2b inhibitors are designed to maintain stability under physiological conditions, exhibiting resistance to hydrolysis or oxidation. They can be synthesized using various organic chemistry methodologies, often involving multiple steps to achieve the precise structural configurations needed for effective inhibition. Additionally, their solubility, molecular weight, and lipophilicity are key factors that are considered during the design and synthesis process, ensuring that these compounds can effectively interact with the target enzyme in relevant biological environments. Moreover, these inhibitors may display a range of binding kinetics, from fast and reversible binding to slow, sustained interactions, which can influence their overall inhibitory profile.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Tyrosine kinase inhibitor, could potentially affect signaling pathways involved in cell growth and differentiation.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Src family kinase inhibitor, might influence cell adhesion and migration processes.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor, could disrupt signaling pathways important for cell survival and proliferation.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

MEK inhibitor, potentially affecting the MAPK/ERK pathway, which could be relevant to "HPA2b" functions.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor, might modulate stress response pathways and apoptosis related to "HPA2b" activity.

SB 202190

152121-30-7sc-202334
sc-202334A
sc-202334B
1 mg
5 mg
25 mg
$31.00
$128.00
$454.00
45
(1)

p38 MAPK inhibitor, could affect inflammatory response pathways "HPA2b" might be involved in.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor, might alter cellular growth and autophagy processes associated with "HPA2b."

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Proteasome inhibitor, could impact protein degradation pathways relevant to "HPA2b's" function.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$111.00
$357.00
8
(0)

Modulates NF-κB and other signaling molecules, potentially affecting inflammation and cell growth.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Modulates various signaling pathways, could enhance cellular stress responses and affect "HPA2b" indirectly.